ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,826.87
-0.38%
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs Yen
155.675
0.00%
Brent Oil
83.76
0.00%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. RepliCel Life Sciences Inc (CE) (REPCF)

  7. RepliCel Life Sciences Inc (CE) (REPCF) ニュース

REPCF

RepliCel Life Sciences (CE) (REPCF)

RepliCel Life Sciences Inc (CE)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:REPCF
日付受信時刻ニュースソース見出しコード企業名
2023/12/0103 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/10/2500 : 10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/10/2002 : 45Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/10/0503 : 23Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/09/0801 : 26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/08/3106 : 15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/08/3002 : 14Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/08/1800 : 22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/05/3119 : 01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/05/1902 : 59Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/04/2102 : 04Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/03/1703 : 40Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/02/0820 : 01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/02/0220 : 02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/01/2700 : 51Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/01/2620 : 01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/01/1802 : 02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/01/1801 : 48Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2023/01/0620 : 02Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2022/12/0920 : 03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2022/10/2601 : 28Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2022/09/2919 : 02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2022/09/1319 : 01Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2022/09/0703 : 36Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2022/08/0500 : 41Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2022/07/2903 : 53Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2022/07/2702 : 46Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2022/07/0802 : 44Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2022/07/0100 : 16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (CE)
2022/06/2919 : 02Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:REPCFRepliCel Life Sciences Inc (CE)
 Showing the most relevant articles for your search:USOTC:REPCF

最近閲覧した銘柄

NYSE
GI
ECPM HOLDINGS, LLC
LATK
SAFUUUSDT
Safuu
COIN
ANSUSD
BIT
UR9ZMS
UniCredit Bank
USOTC
NPEGF
Nippon Electric Glas (PK)
USOTC
NZMEF
Nzme (PK)
COIN
OYSUSD
BIT
UB0TDK
UniCredit Bank
NASDAQ
AAZXJXX
Morgan Stanley Finance L...
BIT
F17735
Vontobel Financial Produ...
NASDAQ
ABAADXX
Morgan Stanley Finance L...
KOSPI
73501BBC
Rainbow New Deal Enterpr...
NASDAQ
KMPH
KemPharm
EU
H427T
H427T
NASDAQ
GMOYX
Gmo Resource Transition ...
NYSE
TOO-B
Teekay Offshore Partners
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有